News summaryInvesting.comNov 8, 2026, 03:04 PM
Cabaletta Bio reports phase 1/2 data for autoimmune therapy
CABAhealthcare
Cabaletta Bio reports phase 1/2 data for autoimmune therapy(摘要待生成)
Loading...
Cabaletta Bio reports phase 1/2 data for autoimmune therapy(摘要待生成)